Literature DB >> 15541319

Decreased absolute amygdala volume in cocaine addicts.

Nikos Makris1, Gregory P Gasic, Larry J Seidman, Jill M Goldstein, David R Gastfriend, Igor Elman, Matthew D Albaugh, Steven M Hodge, David A Ziegler, Fred S Sheahan, Verne S Caviness, Ming T Tsuang, David N Kennedy, Steven E Hyman, Bruce R Rosen, Hans C Breiter.   

Abstract

The amygdala is instrumental to a set of brain processes that lead to cocaine consumption, including those that mediate reward and drug craving. This study examined the volumes of the amygdala and hippocampus in cocaine-addicted subjects and matched healthy controls and determined that the amygdala but not the hippocampus was significantly reduced in volume. The right-left amygdala asymmetry in control subjects was absent in the cocaine addicts. Topological analysis of amygdala isosurfaces (population averages) revealed that the isosurface of the cocaine-dependent group undercut the anterior and superior surfaces of the control group, implicating a difference in the corticomedial and basolateral nuclei. In cocaine addicts, amygdala volume did not correlate with any measure of cocaine use. The amygdala symmetry coefficient did correlate with baseline but not cocaine-primed craving. These findings argue for a condition that predisposes the individual to cocaine dependence by affecting the amygdala, or a primary event early in the course of cocaine use.

Entities:  

Mesh:

Year:  2004        PMID: 15541319     DOI: 10.1016/j.neuron.2004.10.027

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  68 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

2.  Postmortem proteomic analysis in human amygdala of drug addicts: possible impact of tubulin on drug-abusing behavior.

Authors:  P Zill; V Vielsmeier; A Büttner; W Eisenmenger; F Siedler; B Scheffer; H-J Möller; B Bondy
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-08-05       Impact factor: 5.270

3.  Toward brain correlates of natural behavior: fMRI during violent video games.

Authors:  Klaus Mathiak; René Weber
Journal:  Hum Brain Mapp       Date:  2006-12       Impact factor: 5.038

Review 4.  A meeting to remember: meeting on memory and related disorders.

Authors:  Gregory P Gasic; Angel Barco; Jesús Avila; Juan Lerma
Journal:  EMBO Rep       Date:  2006-07-14       Impact factor: 8.807

5.  Cocaine and Pavlovian fear conditioning: dose-effect analysis.

Authors:  Suzanne C Wood; Jonathan Fay; Jennifer R Sage; Stephan G Anagnostaras
Journal:  Behav Brain Res       Date:  2006-11-13       Impact factor: 3.332

6.  Craving is associated with amygdala volumes in adolescent marijuana users during abstinence.

Authors:  Claudia B Padula; Tim McQueeny; Krista M Lisdahl; Jenessa S Price; Susan F Tapert
Journal:  Am J Drug Alcohol Abuse       Date:  2015-02-10       Impact factor: 3.829

Review 7.  Probing the role of AMPAR endocytosis and long-term depression in behavioural sensitization: relevance to treatment of brain disorders, including drug addiction.

Authors:  Y T Wang
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

8.  Emotion, decision-making and substance dependence: a somatic-marker model of addiction.

Authors:  A Verdejo-García; M Pérez-García; A Bechara
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

Review 9.  Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants?

Authors:  Scott Mackey; Martin Paulus
Journal:  Neurosci Biobehav Rev       Date:  2012-12-17       Impact factor: 8.989

10.  Improving the reliability of manual and automated methods for hippocampal and amygdala volume measurements.

Authors:  Khader M Hasan; Otto Pedraza
Journal:  Neuroimage       Date:  2009-05-13       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.